3-(Pyrimidin-2-ylamino)benzoic acid

Catalog No.: 
ACKRNX603
CAS No.: 
198195-06-1
Molecular Formula: 
C11H9N3O2
Molecular Weight: 
215.21
3-(Pyrimidin-2-ylamino)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$53.00In stockInquiry
250mg97%$82.00In stockInquiry
1g97%$168.00InquiryInquiry
5g97%$673.00InquiryInquiry
25g97%$2716.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Pyrimidin-2-ylamino)benzoic acid
IUPAC Name3-(pyrimidin-2-ylamino)benzoic acid
MDL No.MFCD08445169
Molecular FormulaC11H9N3O2
Molecular Weight215.21
SMILESO=C(O)C1=CC=CC(NC2=NC=CC=N2)=C1
InChI KeyJCCQTGJTDPBYJP-UHFFFAOYSA-N
SynonymBenzoic acid, 3-(2-pyrimidinylamino)- (9CI);Benzoic acid, 3-(2-pyrimidinylamino)-;3-(2-PYRIMIDINYLAMINO)BENZOIC ACID
CAS No.198195-06-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKRNX603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9In Stock
  2. Plus
  3. ACCHSK928 route compound structure diagram
    ACCHSK92815151-51-6In Stock
  4. Then
  5. ACKRNX603 route product structure diagram
    ACKRNX603198195-06-1In Stock
Inquiry

2. ACKRNX603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRNX603 route product structure diagram
    ACKRNX603198195-06-1In Stock
Inquiry

3. ACKRNX603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRNX603 route product structure diagram
    ACKRNX603198195-06-1In Stock
Inquiry

Comments (0)